Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is BioNTech a Buy?

TheMotleyFool

0 0

If you invested $10,000 into BioNTech (NASDAQ: BNTX) stock upon its October 2019 IPO, that principal would have turned to about $125,800 as of May 21, 2021. That is several magnitudes better than the S&P 500 index's 42% return during the same period.

Once a little-known underdog, BioNTech has now become a top-tier biotech company that is helping to vaccinate the world against the coronavirus. It is also at the forefront of tackling cancer with its line of therapeutics. Here's why biotech investors should definitely consider the stock.

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Share